219 related articles for article (PubMed ID: 29236513)
41. IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.
Gupta PK; Wagner SR; Wu Q; Shilling RA
Am J Respir Cell Mol Biol; 2017 Jun; 56(6):708-715. PubMed ID: 28118023
[TBL] [Abstract][Full Text] [Related]
42. Obliterative bronchiolitis or chronic lung allograft rejection: a basic science review.
Neuringer IP; Chalermskulrat W; Aris R
J Heart Lung Transplant; 2005 Jan; 24(1):3-19. PubMed ID: 15653373
[No Abstract] [Full Text] [Related]
43. Late airway changes caused by chronic rejection in rat lung allografts.
Uyama T; Winter JB; Groen G; Wildevuur CR; Monden Y; Prop J
Transplantation; 1992 Nov; 54(5):809-12. PubMed ID: 1440846
[TBL] [Abstract][Full Text] [Related]
44. Immune cells in a mouse airway model of obliterative bronchiolitis.
Neuringer IP; Mannon RB; Coffman TM; Parsons M; Burns K; Yankaskas JR; Aris RM
Am J Respir Cell Mol Biol; 1998 Sep; 19(3):379-86. PubMed ID: 9730865
[TBL] [Abstract][Full Text] [Related]
45. Hyaluronan contributes to bronchiolitis obliterans syndrome and stimulates lung allograft rejection through activation of innate immunity.
Todd JL; Wang X; Sugimoto S; Kennedy VE; Zhang HL; Pavlisko EN; Kelly FL; Huang H; Kreisel D; Palmer SM; Gelman AE
Am J Respir Crit Care Med; 2014 Mar; 189(5):556-66. PubMed ID: 24471427
[TBL] [Abstract][Full Text] [Related]
46. PLK1 Inhibition alleviates transplant-associated obliterative bronchiolitis by suppressing myofibroblast differentiation.
Yu J; Xu H; Cui J; Chen S; Zhang H; Zou Y; Zhao J; Le S; Jiang L; Chen Z; Liu H; Zhang D; Xia J; Wu J
Aging (Albany NY); 2020 Jun; 12(12):11636-11652. PubMed ID: 32541091
[TBL] [Abstract][Full Text] [Related]
47. Small animal models of experimental obliterative bronchiolitis.
Jungraithmayr W; Jang JH; Schrepfer S; Inci I; Weder W
Am J Respir Cell Mol Biol; 2013 Jun; 48(6):675-84. PubMed ID: 23392572
[TBL] [Abstract][Full Text] [Related]
48. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
[TBL] [Abstract][Full Text] [Related]
49. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
[TBL] [Abstract][Full Text] [Related]
50. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
[TBL] [Abstract][Full Text] [Related]
51. Chronic lung allograft dysfunction after lung transplantation: the moving target.
Sato M
Gen Thorac Cardiovasc Surg; 2013 Feb; 61(2):67-78. PubMed ID: 23138970
[TBL] [Abstract][Full Text] [Related]
52. Lung transplant rejection: obliterative bronchiolitis.
Spector NM; Connolly MA; Garrity ER
Am J Crit Care; 1996 Sep; 5(5):366-72. PubMed ID: 8870860
[TBL] [Abstract][Full Text] [Related]
53. A relevant experimental model for human bronchiolitis obliterans syndrome.
Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V
J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896
[TBL] [Abstract][Full Text] [Related]
54. [Pathophysiology of obliterative bronchiolitis in lung transplants].
Reynaud-Gaubert M
Rev Mal Respir; 2003 Apr; 20(2 Pt 1):224-32. PubMed ID: 12844020
[TBL] [Abstract][Full Text] [Related]
55. Chronic rejection in single-lung transplantation manifested by obliterative bronchiolitis.
LoCicero J; Robinson PG; Fisher M
J Thorac Cardiovasc Surg; 1990 Jun; 99(6):1059-62. PubMed ID: 2359323
[TBL] [Abstract][Full Text] [Related]
56. Tests of airway function in detecting and monitoring treatment of obliterative bronchiolitis after lung transplantation.
Chacon RA; Corris PA; Dark JH; Gibson GJ
J Heart Lung Transplant; 2000 Mar; 19(3):263-9. PubMed ID: 10713251
[TBL] [Abstract][Full Text] [Related]
57. Spleen Tyrosine Kinase Modulates Fibrous Airway Obliteration and Associated Lymphoid Neogenesis After Transplantation.
Matsuda Y; Wang X; Oishi H; Guan Z; Saito M; Liu M; Keshavjee S; Chow CW
Am J Transplant; 2016 Jan; 16(1):342-52. PubMed ID: 26308240
[TBL] [Abstract][Full Text] [Related]
58. Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts.
Raissadati A; Nykänen AI; Tuuminen R; Syrjälä SO; Krebs R; Arnaudova R; Rouvinen E; Wang X; Poller W; Lemström KB
Transpl Int; 2015 Dec; 28(12):1416-25. PubMed ID: 26174800
[TBL] [Abstract][Full Text] [Related]
59. Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs.
Jonigk D; Merk M; Hussein K; Maegel L; Theophile K; Muth M; Lehmann U; Bockmeyer CL; Mengel M; Gottlieb J; Welte T; Haverich A; Golpon H; Kreipe H; Laenger F
Am J Pathol; 2011 Feb; 178(2):599-608. PubMed ID: 21281792
[TBL] [Abstract][Full Text] [Related]
60. Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.
Mitchell PO; Guidot DM
Am J Respir Crit Care Med; 2007 Dec; 176(11):1161-8. PubMed ID: 17717204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
